AKR1C3

Gene Information
 
Gene Symbol
AKR1C3
 
Aliases
DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS
 
Entrez Gene ID
 
Gene Name
Aldo-keto reductase family 1 member C3
 
Chromosomal Location
10p15.1
 
HGNC ID
 
Summary
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0006693 Biological process Prostaglandin metabolic process IBA 21873635
GO:0006693 Biological process Prostaglandin metabolic process IEP 20036328
GO:0006693 Biological process Prostaglandin metabolic process TAS 9792917
GO:0007186 Biological process G protein-coupled receptor signaling pathway IDA 18508192
GO:0007584 Biological process Response to nutrient IEP 19007764
Protein Information
 
Protein Name
Aldo-keto reductase family 1 member C3, 3-alpha hydroxysteroid dehydrogenase, type II, 3-alpha-HSD type II, brain, chlordecone reductase homolog HAKRb, dihydrodiol dehydrogenase 3, dihydrodiol dehydrogenase X, indanol dehydrogenase, prostaglandin F synthase, testosterone 17-beta-dehydrogenase 5, trans-1,2-dihydrobenzene-1,2-diol dehydrogenase, type IIb 3-alpha hydroxysteroid dehydrogenase
 
Function
Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone
 
Refseq Proteins
 
UniProt
 
PDB
Pathways
 
KEGG
 
Reactome
 

Steroid hormone biosynthesis
Arachidonic acid metabolism
Folate biosynthesis
Metabolic pathways
Ovarian steroidogenesis

 

Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
Synthesis of bile acids and bile salts via 24-hydroxycholesterol
Synthesis of bile acids and bile salts via 27-hydroxycholesterol
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
RA biosynthesis pathway
Retinoid metabolism and transport

Interactions
 
STRING MINT IntAct
ENSP00000242208 P08476 P08476
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Endocrine System Diseases
Disorders of Sex Development
Hermaphroditism
Pseudohermaphroditism
Ambiguous Genitalia
Intersex Conditions
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
Testosterone 
PCOS 
(SNP)-71G 
Rotterdam criteria 
Related 
Caucasian, African-American, Hispanic, Asian (121 PCOS patients and 128 population controls ) 
SNP-71G in HSD17B5 is a functional polymorphism that may contribute to testosterone excess in a subset of PCOS patients. 
Testosterone, Follicle-stimulating hormone (FSH), luteinizing hormone (LH), LH/FSH, and estradiol (E(2)) 
PCOS 
rs898611 
 
Related 
222 PCOS patients, 283 controls 
Our data suggest that there is no association of HSD17B6 and HSD17B5 variants with the occurrence of PCOS in the Chinese population, but the polymorphism of SNP rs898611 is associated with BMI in PCOS patients. 
Testosterone, Androstenedione 
PCOS, hyperandrogenemia 
71A/G HSD17B5 SNP, -71G HSD17B5 
Rotterdam criteria, NIH/NIHCD criteria 
Related 
150 caucasian Greek PCOS women with biochemical hyperandrogenism and chronic anovulation, 51 healthy control subjects 
The -71G HSD17B5 variant is not a major component of the molecular pathogenetic mechanisms of PCOS, although it might contribute to the severity of hyperandrogenemia in women with PCOS and biochemical hyperandrogenism 
Testosterone 
PCOS, hyperandrogenemia 
rs3763676, rs12529, rs7741, rs12387 
 
Related 
Barcelona, Spain (190 girls with precocious pubarche (PP), 71 healthy controls) 
HSD17B5 SNPs predicted to have functional effects do not appear to be a risk factor for PP in girls from Barcelona, despite these girls being at high risk of developing androgen excess in adulthood. 
HSD17B6 
PCOS 
rs1937845 
 
Direct 
Chinese (335 patients with PCOS and 354 controls). 
In conclusion, our findings showed a significant statistical association between HSD17B5 rs1937845 and PCOS risk in Chinese women. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412